Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation
PHASE2
This phase IIa trial studies the side effects of itacitinib when given toge...
Autologous CD34+ Hematopoietic Stem Cells Transduced ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for the Human ADA Gene
PHASE1
The aim of this study is to assess the safety and efficacy of autologous tr...
CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
PHASE1
This phase I trial studies the best dose of total body irradiation when giv...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
PHASE2
In this study, treosulfan is evaluated for conditioning in allogenic stem c...